Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Journal articles
  4. Understanding the interactions of diruthenium anticancer agents with amino acids
 
research article

Understanding the interactions of diruthenium anticancer agents with amino acids

Nazarov, Alexey A.  
•
Mendoza-Ferri, Maria-Grazia
•
Hanif, Muhammad
Show more
October 1, 2018
JBIC Journal of Biological Inorganic Chemistry

The dinuclear anticancer agents 1,n-bis{chlorido3-(oxo-kappa O)-2-methyl-4-(1H)-pyridinonato-kappa O4-ruthenium(II)}alkane (PyRu2n) exhibit high antiproliferative activity in human cancer cell. Reactivity studies with DNA and protein revealed uncommon protein-DNA and DNA-DNA crosslinking ability. We report here studies on the reactions of the diruthenium organometallics PyRu26 and PyRu28 in comparison with a mononuclear analogue PyRu3 with amino acids using mass spectrometry and NMR spectroscopy. The compounds behave very similarly, independent of the spacer length between the metal center and of the nuclearity of the complexes. Incubation with L-cysteine (Cys) results in fast release of the pyridone ligand, with the Ru complexes able to form Cys adducts. In contrast, L-methionine forms, initially, adducts with the metal centers, but over time, the adducts decompose. Similar behavior was observed for the reaction with L-histidine with [Ru(eta(6)-p-cymene)(L-histidine)] species detected.

  • Details
  • Metrics
Type
research article
DOI
10.1007/s00775-018-1597-x
Web of Science ID

WOS:000448583900020

Author(s)
Nazarov, Alexey A.  
Mendoza-Ferri, Maria-Grazia
Hanif, Muhammad
Keppler, Bernhard K.
Dyson, Paul J.  
Hartinger, Christian G.  
Date Issued

2018-10-01

Publisher

Springer

Published in
JBIC Journal of Biological Inorganic Chemistry
Volume

23

Issue

7

Start page

1159

End page

1164

Subjects

Biochemistry & Molecular Biology

•

Chemistry, Inorganic & Nuclear

•

Chemistry

•

amino acid interaction

•

bioorganometallics

•

dinuclear compounds

•

mass spectrometry

•

nmr spectroscopy

•

ruthenium(arene) complexes

•

ruthenium(ii)-arene complexes

•

ruthenium complexes

•

antitumor-activity

•

in-vitro

•

phase-i

•

cytotoxicity

•

drugs

•

dna

•

chemotherapy

•

metallodrugs

Editorial or Peer reviewed

REVIEWED

Written at

EPFL

EPFL units
LCOM  
LCS  
Available on Infoscience
December 13, 2018
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/152756
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés